23andMe replicates over 180 genetic associations with Web-based research platform

August 17, 2011

MOUNTAIN VIEW, CA - (August 17, 2011) - 23andMe, Inc., a leading personal genetics company has replicated over 180 genetic associations from a list of associations curated by the National Human Genome Research Institute's Office of Population Genomics ("GWAS Catalog") demonstrating that self-reported medical data is effective and reliable to validate known genetic associations. The results, available online in the journal PLoS ONE establish 23andMe's methodology as a significant research platform in a new era of genetic research.

"In this paper we confirm that self reported data from our customers has the potential to yield data of comparable quality as data gathered using traditional research methods," stated 23andMe Chief Business Officer Ashley Dombkowski. "As the 23andMe platform has been clearly shown to replicate known genetic associations as well as discover new ones, we have established our research platform as an innovative model for genetic research which has the power to move scientific research forward faster and more cost effectively working in collaboration with academic and commercial researchers," continued Dombkowski.

This study investigated nearly 400 previously reported genetic associations for 50 different conditions in more than 20,000 individuals of European descent. 23andMe replicated approximately 75 percent of the associations they expected to replicate, demonstrating that high quality findings of genetic associations can be derived from self-reported data. The study also provided the first independent replication for several associations.

A genetic association study on such a scale has never before been attempted however 23andMe's innovative research platform allows researchers to simultaneously investigate hundreds of genetic factors in dozens of different diseases. This study took only about a year from start to publish.

A number of associations reported in very large meta-analyses have not been replicated because of the difficulty in assembling comparably sized cohorts of patients. There was a clear need to quickly and reliably gather retrospective phenotype information from large cohorts to validate existing associations as well as to discover new ones.

"This study demonstrates that this is a powerful method for performing genetic research," explained Senior Scientist Joyce Tung. "The potential of 23andMe's web-based platform is further enhanced by our ability to contact individuals multiple times and ask follow-up questions which puts us in a position to zero-in on associations."

"This flexibility to follow GWAS outcomes with efficient and cost-effective follow-up questionnaires is the foundation for future research aimed at prevention, better treatments, and potentially cures for a multitude of diseases and conditions," Tung concluded.

These results continue to validate 23andMe's methodology in combining self-reported data on phenotypes gathered via web-based questionnaires and genotypic data derived from self-collected saliva samples. 23andMe had previously published its first proof-of-concept results in the journal PLoS Genetics in June 2010 which reported novel associations for unusual traits such as asparagus anosmia and photic sneeze reflex and replicated associations for other traits, and recently published discovery of two novel genetic associations for Parkinson's disease, also in PLoS Genetics.

23andMe chose to publish its results in PLoS ONE because of the journal's open-access policy, which allows anyone--including 23andMe customers who contributed to the research--to freely access the study. Customers will also see the results incorporated into the reports available in their online accounts over time. The online paper may be viewed at PLOS ONE.
About 23andMe

23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service® enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. More information is available at www.23andme.com.

Media Contacts:

Rubenstein Communications
1345 Ave of the Americas
New York, NY 10105

Jane Rubinstein, 212-843-8287, jrubinstein@rubenstein.com
Rachel Nagler, 212-843-8017, rnagler@rubenstein.com

23andMe, Inc.

Related Genetic Research Articles from Brightsurf:

Yale team finds way to protect genetic privacy in research
In a new report, a team of Yale scientists has developed a way to protect people's private genetic information while preserving the benefits of a free exchange of functional genomics data between researchers.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Genetic doppelgaengers: Emory research provides insight into two neurological puzzles
Insight into the pathological mechanisms behind two devastating neurodegenerative diseases: the most common inherited form of amyotrophic lateral sclerosis/ frontotemporal dementia (ALS/FTD) and spinocerebellar ataxia type 36 (SCA36).

Lupus study illustrates the importance of diversity in genetic research
Scientists at the HudsonAlpha Institute for Biotechnology have pinpointed epigenetic differences in the way lupus affects black women compared to other lupus patients, revealing important mechanics of the puzzling disease.

Quantifying Hispanic and Latinx populations' interest in genetic research participation
Researchers are increasingly prioritizing the need for diversity in genetics and genomics research.

New research uncovers how common genetic mutation drives cancer
A new, multicenter study led by Fred Hutchinson Cancer Research Center and Memorial Sloan Kettering Cancer Center determined how a single mutation in splicing factor 3b subunit 1 (SF3B1), the most frequently mutated splicing factor gene, drives the formation of many cancers.

Cancer research -- The genetic context is crucial
An Ludwig-Maximilians-Universitaet (LMU) in Munich team has uncovered a mechanism behind the variability in the clinical course of Ewing sarcoma.

Scientists hope genetic research will lead to new breakthroughs in weed control
An article featured in the journal Weed Science sheds important new light on the genetics and potential control of Palmer amaranth and waterhemp - two troublesome Amaranthus species weeds that are resistant to multiple herbicides.

Research identifies genetic causes of poor sleep
The largest genetic study of its kind ever to use accelerometer data to examine how we slumber has uncovered a number of parts of our genetic code that could be responsible for causing poor sleep quality and duration.

Defining the responsibility to recontact research participants with new genetic findings
ASHG, along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants when new findings emerge that suggest their genetic information should be interpreted differently, which would allow participants to benefit from current genomics advances.

Read More: Genetic Research News and Genetic Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.